Rallybio Corp (RLYB)
1.47
-0.02
(-1.34%)
USD |
NASDAQ |
Jun 26, 13:14
Rallybio Total Assets (Quarterly): 99.36M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 99.36M |
| December 31, 2023 | 115.62M |
| September 30, 2023 | 133.19M |
| June 30, 2023 | 147.58M |
| March 31, 2023 | 162.32M |
| December 31, 2022 | 180.44M |
| September 30, 2022 | 143.67M |
| Date | Value |
|---|---|
| June 30, 2022 | 155.61M |
| March 31, 2022 | 169.35M |
| December 31, 2021 | 182.18M |
| September 30, 2021 | 193.86M |
| June 30, 2021 | 120.10M |
| March 31, 2021 | 129.35M |
| December 31, 2020 | 141.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
99.36M
Minimum
Mar 2024
193.86M
Maximum
Sep 2021
148.18M
Average
145.62M
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 171.97B |
| Adial Pharmaceuticals Inc | 6.684M |
| Eliem Therapeutics Inc | 109.33M |
| Monogram Technologies Inc | 12.54M |
| TG Therapeutics Inc | 373.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 10.20M |
| Shareholders Equity (Quarterly) | 89.16M |